{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Rosemead",
      "state": "CA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "98258",
      "recalling_firm": "ANTHONY TRINH, 123Herbals LLC",
      "address_1": "7214 Berne St",
      "address_2": "N/A",
      "postal_code": "91770-3844",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "USA nationwide",
      "recall_number": "D-0388-2026",
      "product_description": "SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China",
      "product_quantity": "N/A",
      "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA analysis  revealed the presence of undeclared meloxicam.",
      "recall_initiation_date": "20251020",
      "center_classification_date": "20260313",
      "report_date": "20260311",
      "code_info": "All lots within expiry"
    }
  ]
}